Patients with ROS1 fusions shared some features in common with ALK-positive patients in previous studies, such as younger age, female sex, never-smoking status, adenocarcinoma, advanced stage and Asian ethnicity [15, 16]. The gene discussed is ALK; the disease is adenocarcinoma.